HCA Healthcare, Inc.

As of June 30, 2026, HCA Healthcare Inc carries a market capitalization of 84.47B, placing it among publicly traded companies globally. Its enterprise value stands at 138.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

HCA Healthcare Inc's next confirmed earnings release is scheduled for October 27, 2026.

As of June 30, 2026, HCA Healthcare Inc has 217.96M shares outstanding.

As of June 30, 2026, HCA Healthcare Inc trades at a trailing price-to-earnings ratio of 12.68. The price-to-sales ratio is 1.11, and the price-to-book ratio stands at -12.72.

As of June 30, 2026, HCA Healthcare Inc trades at an EV/EBITDA multiple of 8.77 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.77 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.42 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. HCA Healthcare Inc trades at an EV/FCF ratio of 17.66, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 138.45B versus a market cap of 84.47B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, HCA Healthcare Inc maintains a current ratio of 0.99, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,606.48, indicating conservative leverage, while an interest coverage ratio of 6.82 demonstrates adequate ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on invested capital (ROIC) comes in at 20.63 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 11.14, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 16.41, useful for judging operating efficiency across full business cycles. The company generates approximately 244,554.86 in revenue per employee across its workforce of 319,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 25.94 indicates how many times HCA Healthcare Inc sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, HCA Healthcare Inc recorded 2.02B in income tax expense. That works out to an effective tax rate of 20.44, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 9.87B, leaving 6.84B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, HCA Healthcare Inc's stock has gained approximately 5.75% over the past 52 weeks. The 50-day moving average sits at 431.86, while the 200-day moving average is 445.19.

Over the twelve months ended June 30, 2026, HCA Healthcare Inc generated 78.01B in revenue and converted that into 6.84B in net income, yielding earnings per share of 34.28. EBITDA reached 15.80B, while operating income came in at 12.07B.

As of June 30, 2026, HCA Healthcare Inc holds 1.01B in cash and equivalents against 51.55B in total debt, resulting in a net debt position of 48.71B. Total book value stands at -6.64B, with working capital of -122.00M providing operational flexibility.

HCA Healthcare Inc produced 11.12B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.13B in capital expenditures, free cash flow totaled 6.00B - equivalent to 26.80 per share.

Over the twelve months ended June 30, 2026, HCA Healthcare Inc posted a gross margin of 42.58, reflecting its pricing power and cost economics. The operating margin of 15.48 and net profit margin of 8.77 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, HCA Healthcare Inc paid dividends of 3.05 per share. The dividend payout ratio of 7.69 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.75, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 6.51, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to HCA Healthcare Inc shareholders.

As of June 30, 2026, HCA Healthcare Inc has an Altman Z-Score of 2.83, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.